« Back to Record
Citation APA

Zeuzem, S., Buggisch, P., Agarwal, K., Marcellin, P., Sereni, D., Klinker, H., Moreno, C., Zarski, J.-P., Horsmans, Y., Mo, H., Arterburn, S., Knox, S., Oldach, D., McHutchison, J. G., Manns, M. P., & Foster, G. R. (2012). The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology, 55(3), 749-758. doi:10.1002/hep.24744


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156143

Zeuzem, S., Buggisch, P., Agarwal, K., Marcellin, P., Sereni, D., Klinker, H., Moreno, C., Zarski, J.-P., Horsmans, Y., Mo, H., Arterburn, S., Knox, S., Oldach, D., McHutchison, J. G., Manns, M. P., & Foster, G. R. (2012). The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology, 55(3), 749-758. doi:10.1002/hep.24744